Stoke Therapeutics: Chief medical officer Ticho Barry sold 1,051 shares

What happened Ticho Barry, chief medical officer, sold 1,051 shares of Stoke Therapeutics on Oct 1, 2026. The Form 4 reports a weighted average price of $26.16 per share and total proceeds of $27,494.

Key details

• Transaction date: Oct 1, 2026. Form filed Oct 2, 2026.
• Price: reported weighted average $26.16 per share; shares were sold in multiple transactions at prices ranging from $25.91 to $26.51 per share (see footnote).
• Shares sold: 1,051. Total reported proceeds: $27,494.
• Shares owned after the transaction: not stated in the Form 4.
• Footnotes: F1: sale executed pursuant to a Rule 10b5-1 trading plan adopted Nov 19, 2025. F2: price is a weighted average; reporting person will provide a breakdown of shares sold at each price on request.

Why it may matter

• This was an open-market/private sale, not an option exercise or gift.
• The sale was executed under a Rule 10b5-1 trading plan.
  A filing does not show why the insider traded or why the company acted.